X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (40) 40
hematology (33) 33
female (31) 31
male (31) 31
adolescent (19) 19
child (19) 19
adult (18) 18
pediatrics (17) 17
anemia (15) 15
beta-thalassemia (12) 12
child, preschool (12) 12
sickle cell disease (12) 12
children (11) 11
beta-thalassemia - complications (10) 10
iron overload (10) 10
lebanon (10) 10
middle aged (10) 10
iron overload - etiology (9) 9
oncology (9) 9
young adult (9) 9
anemia, sickle cell - complications (8) 8
anemia, sickle cell - therapy (8) 8
ferritins - blood (8) 8
infant (8) 8
iron chelating agents - therapeutic use (8) 8
thalassemia (8) 8
anemia, sickle cell - drug therapy (7) 7
blood transfusion (7) 7
infant, newborn (7) 7
lebanon - epidemiology (7) 7
splenectomy (7) 7
therapy (7) 7
beta-thalassemia - drug therapy (6) 6
chelation therapy (6) 6
deferoxamine (6) 6
disease (6) 6
hydroxyurea (6) 6
sickle cell anemia (6) 6
transfusion reaction (6) 6
administration, oral (5) 5
anemia, sickle cell - blood (5) 5
follow-up studies (5) 5
hemoglobin (5) 5
iron - analysis (5) 5
iron overload - drug therapy (5) 5
mutation (5) 5
review (5) 5
transfusion (5) 5
treatment outcome (5) 5
anemia, sickle cell - metabolism (4) 4
clinical trials (4) 4
epidemiology (4) 4
hospitals (4) 4
incidence (4) 4
iron chelating agents - adverse effects (4) 4
iron chelation (4) 4
liver - chemistry (4) 4
management (4) 4
medicine (4) 4
mortality (4) 4
patients (4) 4
prevalence (4) 4
prospective studies (4) 4
risk factors (4) 4
rotavirus (4) 4
safety (4) 4
serum ferritin (4) 4
trial (4) 4
abridged index medicus (3) 3
adults (3) 3
analysis (3) 3
anemia, sickle cell - diagnosis (3) 3
antisickling agents - therapeutic use (3) 3
article (3) 3
benzoates - therapeutic use (3) 3
beta-thalassemia - blood (3) 3
beta-thalassemia - therapy (3) 3
bone marrow (3) 3
butyrates - administration & dosage (3) 3
butyrates - adverse effects (3) 3
butyrates - therapeutic use (3) 3
chelation-therapy (3) 3
clinical medicine (3) 3
combined modality therapy (3) 3
deferasirox (3) 3
deferiprone (3) 3
deferoxamine - therapeutic use (3) 3
diagnosis, differential (3) 3
fatty acids (3) 3
ferritin (3) 3
fetal hemoglobin - biosynthesis (3) 3
fetal hemoglobin - genetics (3) 3
gastroenteritis (3) 3
gene (3) 3
gene expression (3) 3
genes (3) 3
genotype (3) 3
haplotypes (3) 3
health aspects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood Reviews, ISSN 0268-960X, 2009, Volume 23, Issue 1, pp. S9 - S13
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2012, Volume 130, Issue 6, pp. 1414 - 1416
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0161345
Journal Article
Journal Article
Journal Article
BioMed Research International, ISSN 2314-6133, 01/2015, Volume 2015
  Thalassemia intermedia (TI), also known as nontransfusion dependent thalassemia (NTDT), is a type of thalassemia where affected patients do not require... 
Complications and side effects | Thalassemia | Care and treatment | Spinal cord | Hospitals | Nuclear magnetic resonance--NMR | Disease | Anemia | Mortality | Bones | Mutation | Radiation therapy | Chelation therapy | Morbidity
Journal Article
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2015, Volume 62, Issue 8, pp. 1427 - 1436
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 509 - 509
Abstract Background: Sickle cell disease (SCD) is a genetic disorder caused by a mutated hemoglobin S (HbS) that polymerizes in the deoxygenated state and... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2013, Volume 88, Issue 11, pp. E255 - E260
Journal Article